Cargando…

HOMA-IR is an effective biomarker of non-alcoholic fatty liver disease in non-diabetic population

OBJECTIVES: This study aimed to investigate the correlation between homeostasis model assessment of insulin resistance (HOMA-IR) and non-alcoholic fatty liver disease (NAFLD) in the non-diabetic population and establish its diagnostic efficacy. METHODS: This observational study involved participants...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Pei, Cai, Xiangsheng, Yu, Xiaozhou, Huang, Lu, Chen, Xi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590044/ https://www.ncbi.nlm.nih.gov/pubmed/37862786 http://dx.doi.org/10.1177/03000605231204462

Ejemplares similares

Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population
por: Zeng, Pei, et al.
Publicado: (2023)

Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population
por: Lind, Lars, et al.
Publicado: (2020)

Neglected features of lifestyle: Their relevance in non-alcoholic fatty liver disease
por: Trovato, Francesca M, et al.
Publicado: (2016)

Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors
por: Huang, Xin-Juan, et al.
Publicado: (2023)

Prevalence of sarcopenia using different methods in patients with non-alcoholic fatty liver disease
por: Almeida, Naiade Silveira, et al.
Publicado: (2022)

Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study
por: Pereira, Evelyn Nunes Goulart da Silva, et al.
Publicado: (2021)

Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease
por: Biolato, Marco, et al.
Publicado: (2019)

Estimation of visceral fat is useful for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease
por: Hernández-Conde, Marta, et al.
Publicado: (2020)

Skeletal muscle loss is associated with diabetes in middle-aged and older Chinese men without non-alcoholic fatty liver disease
por: Chen, Ling-Yan, et al.
Publicado: (2021)

Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients
por: Zelber-Sagi, Shira, et al.
Publicado: (2017)

Pediatric non-alcoholic fatty liver disease and kidney function: Effect of HSD17B13 variant
por: Di Sessa, Anna, et al.
Publicado: (2020)

Impact of sodium glucose cotransporter-2 inhibitors on liver steatosis/fibrosis/inflammation and redox balance in non-alcoholic fatty liver disease
por: Bellanti, Francesco, et al.
Publicado: (2022)

Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease
por: Gelli, Chiara, et al.
Publicado: (2017)

Are HOMA-IR and HOMA-B good predictors for diabetes and pre-diabetes subtypes?
por: Khalili, Davood, et al.
Publicado: (2023)

HOMA-IR index in non-diabetic patient, a reliable method for early diagnosis of liver steatosis
por: Motamed, Behrang, et al.
Publicado: (2022)

Red blood cell distribution width derivatives in alcohol-related liver cirrhosis and metabolic-associated fatty liver disease
por: Michalak, Agata, et al.
Publicado: (2022)

Non-alcoholic steatohepatitis and the risk of myocardial infarction: A population-based national study
por: Ghoneim, Sara, et al.
Publicado: (2020)

Matrix metalloproteases and their tissue inhibitors in non-alcoholic liver fibrosis of human immunodeficiency virus-infected patients
por: Collazos, Julio, et al.
Publicado: (2017)

Characterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort
por: Khoudari, George, et al.
Publicado: (2019)

Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease
por: Salgado Alvarez, Giovanni Alejandro, et al.
Publicado: (2022)

Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population
por: Liu, Xiao-Lin, et al.
Publicado: (2016)

Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study
por: Lemaitre, Rozenn N., et al.
Publicado: (2018)

Prevalence of insulin resistance and identifying HOMA1-IR and HOMA2-IR indexes in the Middle Black Sea region of Turkey
por: Demir, Ayşe Kevser, et al.
Publicado: (2020)

Non-ALT biomarkers for markedly abnormal liver histology among Chinese persistently normal alanine aminotransferase-chronic hepatitis B patients
por: Cheng, Jin-Lin, et al.
Publicado: (2017)

The HOMA-Adiponectin (HOMA-AD) Closely Mirrors the HOMA-IR Index in the Screening of Insulin Resistance in the Brazilian Metabolic Syndrome Study (BRAMS)
por: Vilela, Brunna Sullara, et al.
Publicado: (2016)

Total cholesterol to high-density lipoprotein ratio and nonalcoholic fatty liver disease in a population with chronic hepatitis B
por: Zhou, Yu-Ge, et al.
Publicado: (2022)

High HOMA-IR Index in Healthcare Shift Workers
por: Ledda, Caterina, et al.
Publicado: (2019)

Associations of the HOMA2‐%B and HOMA2‐IR with progression to diabetes and glycaemic deterioration in young and middle‐aged Chinese
por: Fan, Baoqi, et al.
Publicado: (2022)

Risk factors and urinary biomarkers of non-albuminuric and albuminuric chronic kidney disease in patients with type 2 diabetes
por: Korbut, Anton I, et al.
Publicado: (2019)

Ancestral Effect on HOMA-IR Levels Quantitated in an American Population of Mexican Origin
por: Qu, Hui-Qi, et al.
Publicado: (2012)

Prevalence of nonalcoholic fatty liver disease and its association with age in patients with type 2 diabetes mellitus
por: Yamane, Ryosuke, et al.
Publicado: (2022)

Acylcarnitine: Useful biomarker for early diagnosis of hepatocellular carcinoma in non-steatohepatitis patients
por: Takaya, Hiroaki, et al.
Publicado: (2019)

Association between endotoxemia and histological features of nonalcoholic fatty liver disease
por: Kitabatake, Hiroyuki, et al.
Publicado: (2017)

Interrelationship between physical activity and depression in nonalcoholic fatty liver disease
por: Weinstein, Ali A, et al.
Publicado: (2022)

Impact of Duration of N-Acetylcysteine in Non-Acetaminophen–Induced Acute Liver Failure
por: Bass, Stephanie N., et al.
Publicado: (2021)

HOMA-IR is associated with significant angiographic coronary artery disease in non-diabetic, non-obese individuals: a cross-sectional study
por: Mossmann, Márcio, et al.
Publicado: (2015)

Birth-weight, insulin levels, and HOMA-IR in newborns at term
por: Simental-Mendía, Luis E, et al.
Publicado: (2012)

Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history
por: Magrì, Salvatore, et al.
Publicado: (2019)

Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease
por: Dai, Yi-Ning, et al.
Publicado: (2022)

Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis C
por: Paranaguá-Vezozzo, Denise C, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d5h57dvq9hk1nrugr03v4cn1aa